Aoyagi Y, Kano Y, Tohyama K et al (2022) Clinical utility of comprehensive genomic profiling in Japan: result of PROFILE-F study. PLoS ONE 17(3):e0266112

Article  CAS  PubMed  PubMed Central  Google Scholar 

Appay R, Dehais C, Maurage CA et al (2019) CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas. Neuro Oncol 21(12):1519–1528

CAS  PubMed  PubMed Central  Google Scholar 

Bady P, Sciuscio D, Diserens A-C et al (2012) MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Acta Neuropathol 124(4):547–560

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ballester LY, Fuller GN, Powell SZ et al (2017) Retrospective analysis of molecular and immunohistochemical characterization of 381 primary brain tumors. J Neuropathol Exp Neurol 76(3):179–188

CAS  PubMed  Google Scholar 

Bell EH, Zhang P, Shaw EG et al (2020) Comprehensive genomic analysis in NRG Oncology/RTOG 9802: a Phase III trial of radiation versus radiation plus procarbazine, lomustine (CCNU), and vincristine in high-risk low-grade glioma. J Clin Oncol 38(29):3407–3417

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beroukhim R, Mermel CH, Porter D et al (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463(7283):899–905

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Brennan CW, Verhaak RG, McKenna A et al (2013) The somatic genomic landscape of glioblastoma. Cell 155(2):462–477

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372(26):2481–2498

Christians A, Hartmann C, Benner A et al (2012) Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma. PLoS ONE 7(3):e33449

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Cibulskis K, Lawrence MS, Carter SL et al (2013) Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 31(3):213–219

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clarke M, Mackay A, Ismer B et al (2020) Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes. Cancer Discov 10(7):942–963

Article  CAS  PubMed  PubMed Central  Google Scholar 

DeSisto J, Lucas JT Jr, Xu K et al (2021) Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma. Nat Commun 12(1):5531

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Do H, Dobrovic A (2015) Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization. Clin Chem 61(1):64–71

Article  CAS  PubMed  Google Scholar 

Dobin A, Davis CA, Schlesinger F et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1):15–21

Article  CAS  PubMed  Google Scholar 

Ellison DW, Aldape KD, Capper D et al (2020) cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors. Brain Pathol 30(5):863–866

Article  PubMed  PubMed Central  Google Scholar 

Esteller M, Hamilton SR, Burger PC et al (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59(4):793–797

CAS  PubMed  Google Scholar 

Frattini V, Trifonov V, Chan JM et al (2013) The integrated landscape of driver genomic alterations in glioblastoma. Nat Genet 45(10):1141–1149

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guerreiro Stucklin AS, Ryall S, Fukuoka K et al (2019) Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas. Nat Commun 10(1):4343

Article  ADS  PubMed  PubMed Central  Google Scholar 

Guo Q, Lakatos E, Bakir IA et al (2022) The mutational signatures of formalin fixation on the human genome. Nat Commun 13(1):4487

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Hatanaka Y, Kuwata T, Morii E et al (2021) The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicine. Pathol Int 71(11):725–740

Article  PubMed  PubMed Central  Google Scholar 

Hegi ME, Liu L, Herman JG et al (2008) Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 26(25):4189–4199

Article  CAS  PubMed  Google Scholar 

Higa N, Akahane T, Yokoyama S et al (2020) A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas. Cancer Sci 111(10):3902–3911

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ji MS, Eldred BSC, Liu R et al (2020) Targeted next-generation sequencing of 565 neuro-oncology patients at UCLA: a single-institution experience. Neurooncol Adv 2(1):vdaa009

PubMed  PubMed Central  Google Scholar 

Kohno T, Kato M, Kohsaka S et al (2022) C-CAT: the national datacenter for cancer genomic medicine in Japan. Cancer Discov 12(11):2509–2515

Article  PubMed  PubMed Central  Google Scholar 

Krueger F, Andrews SR (2011) Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics 27(11):1571–1572

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li BK, Vasiljevic A, Dufour C et al (2020) Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study. Acta Neuropathol 139(2):223–241

Article  CAS  PubMed  Google Scholar 

Li H, Durbin R (2010) Fast and accurate long-read alignment with Burrows–Wheeler transform. Bioinformatics 26(5):589–595

Article  PubMed  PubMed Central  Google Scholar 

Lopez GY, Van Ziffle J, Onodera C et al (2019) The genetic landscape of gliomas arising after therapeutic radiation. Acta Neuropathol 137(1):139–150

Article  CAS  PubMed  Google Scholar 

Lorenz J, Rothhammer-Hampl T, Zoubaa S et al (2020) A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology. Acta Neuropathol Commun 8(1):124

Article  CAS  PubMed  PubMed Central  Google Scholar 

Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin M (2011) Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17(1):10–12

Article  Google Scholar 

Malley DS, Hamoudi RA, Kocialkowski S et al (2011) A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts. Acta Neuropathol 121(5):651–661

Article  CAS  PubMed  Google Scholar 

Nassar LR, Barber GP, Benet-Pages A et al (2023) The UCSC genome browser database: 2023 update. Nucleic Acids Res 51(D1):D1188–D1195

Article  CAS  PubMed  Google Scholar 

Nikiforova MN, Wald AI, Melan MA et al (2016) Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors. Neuro Oncol 18(3):379–387

Article  CAS  PubMed  Google Scholar 

Ostrom QT, Gittleman H, Fulop J et al (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol 17(Suppl 4):iv1–iv62

Palmisano WA, Divine KK, Saccomanno G et al (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60(21):5954–5958

CAS  PubMed  Google Scholar 

Paugh BS, Qu C, Jones C et al (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28(18):3061–3068

Article